Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Crescent Biopharma, Inc.

NASDAQ: CBIO · Life Sciences · 8 alerts · CIK 1253689

Share price
$13.50Close, Nov 16
Market cap
$525M
Shares outstanding
38.9MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Crescent Biopharma, Inc. filings on SEC EDGAR ↗

4:03 PM ET Form 4
Insider Selling

Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock

Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).

Value
$11.2K
Shares
623
Price
$17.90
Role
CMO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling

Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock

Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).

Value
$77.2K
Shares
4,570
Average price
$16.90
Role
President and COO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling

Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock

Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).

Value
$10.2K
Shares
568
Price
$17.90
Role
CFO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling

Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock

Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).

Value
$160K
Shares
9,447
Average price
$16.91
Role
CEO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling

Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock

Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).

Value
$11.1K
Shares
620
Price
$17.90
Holding change
-3.2%
Trade date
Sep 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.